CN Patent

CN117479930A — 用于治疗癫痫发作病症的药物组合物和方法

Assigned to Spear Therapy Co ltd · Expires 2024-01-30 · 2y expired

What this patent protects

本公开涉及用于在“难治性癫痫”(TRE)的治疗中用于减少癫痫发作频率的大麻二酚(CBD)的透皮施用。

USPTO Abstract

本公开涉及用于在“难治性癫痫”(TRE)的治疗中用于减少癫痫发作频率的大麻二酚(CBD)的透皮施用。

Drugs covered by this patent

Patent Metadata

Patent number
CN117479930A
Jurisdiction
CN
Classification
—
Expires
2024-01-30
Drug substance claim
No
Drug product claim
No
Assignee
Spear Therapy Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.